Skip to main content

Table 3 Clearance and persistency rates of HR-HPV infections at the different follow-up intervals with the corresponding Odds ratio and p-values

From: 14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology

Follow-up interval (Number of evaluated patients and their types of HR-HPV infection) Clearance rate (%)a Persistency rate (%)b Odds ratio (95% CI) P-value
I follow-up (Total Number n = 271)
 HPV mRNA pos/ DNA pos = 110 n = 112 (41.3%) n = 159 (58.6%) 29.2 (13.2–64.6) < 0.0001
 HPV mRNA pos /DNA neg = 8
 HPV mRNA neg/DNA pos = 49
 HPV mRNA neg/DNA neg = 104
II follow-up (Total Number n = 151)
 HPV mRNA pos/ DNA pos = 80 n = 58 (38.4%) n = 93 (61.6%) 3.23 (1.4–7.2) 0.004
 HPV mRNA pos /DNA neg = 6
 HPV mRNA neg/DNA pos = 13
 HPV mRNA neg/DNA neg = 52
III follow-up (Total Number n = 90)
 HPV mRNA pos/ DNA pos = 46 n = 44 (48.4%) N = 46 (51.2%) 10.3 (0.5–197.8) 0.12
 HPV mRNA neg/DNA neg = 44
  1. aIncluding HR-HPV mRNA and/or HPV DNA-negative patients
  2. b Including HR-HPV mRNA and/or HPV DNA-positive patients
\